The goal of the CEVT is to improve the prevention, diagnosis, and treatment of emerging viral diseases through a multidisciplinary approach that promotes collaboration among programs in basic and clinical research, in order to enhance the understanding of and diagnosis of viruses and the diseases they cause in our region and across the globe. We engage in multidisciplinary, basic and translational research on infectious viruses, provide surveillance and detection for current and future viral threats, provide cutting edge diagnostics and access to national clinical trials, and educate physicians, scientists and the community about prevention, treatment and the science of viral-mediated diseases.
Coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with the virus will experience mild to moderate respiratory illness and recover without requiring special treatment. However, some will become seriously ill and require medical attention. Older people and those with underlying medical conditions like cardiovascular disease, diabetes, chronic respiratory disease, or cancer are more likely to develop serious illness. (World Health Organization)
Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox is a potentially serious viral illness that typically involves flu-like symptoms, swelling of the lymph nodes and a rash that includes bumps that are initially filled with fluid before scabbing over. Illness could be confused with a sexually transmitted infection like syphilis or herpes, or with chickenpox.